Test Price
2,800 AED✅ Home Collection Available
WDR73 Gene Galloway-Mowat Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The WDR73 Gene Galloway-Mowat Syndrome Genetic Test is a next‑generation sequencing (NGS) assay that comprehensively analyses the entire WDR73 gene to identify pathogenic variants associated with Galloway‑Mowat syndrome—a rare dysmorphology condition featuring microcephaly, neurological impairment, and early‑onset nephrotic syndrome. This test is designed for pediatricians, neonatologists, and clinical geneticists seeking definitive molecular confirmation in infants and children presenting with microcephaly and proteinuria. It also supports family planning and carrier screening in at‑risk families.
| Feature | Our Test (WDR73 NGS) | Closest Alternative (Sanger Sequencing Panel) |
|---|---|---|
| Precision / Sensitivity | ≥99.9% for single nucleotide variants and small indels across all coding exons | ~95% per amplicon; may miss deep intronic or large rearrangements |
| Methodology | Next Generation Sequencing (NGS) with full bioinformatics pipeline | Bidirectional Sanger sequencing of selected exons |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) advises: “When a child shows early nephrotic‑range proteinuria together with dysmorphic features, a timely WDR73 genetic test can provide a conclusive diagnosis and guide renal and neurological management. However, a negative result does not exclude the syndrome if clinical suspicion remains high, and all results must be correlated with the patient’s full phenotype.”
Medication Advisory
⚠️ Do Not Discontinue Prescribed Medication
Do not stop or modify any prescribed medication without consulting your treating physician. Genetic test results complement clinical care and are not a substitute for ongoing medical management.
Exclusion Criteria & Emergency Red Flags
- This test is not indicated for acute medical emergencies; if the patient experiences sudden kidney failure, seizures, or severe dehydration, seek immediate emergency care.
- Minors under 18 years require guardian consent and must be accompanied by a legal representative, in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability and Federal Law No. 2 of 2019 concerning use of ICT in health fields.
- Samples that are hemolysed or improperly stored will be rejected; a repeat collection may be arranged at no additional charge if logistics fault is identified.
Patient FAQ & Clinical Guidance
1. What is the WDR73 Gene Galloway-Mowat Syndrome NGS Test and how is it performed?
This NGS test analyzes the WDR73 gene to diagnose Galloway-Mowat syndrome with 99.9% accuracy using a blood sample. A small amount of whole blood (or extracted DNA) is collected via sterile venipuncture or a finger‑prick FTA card, then sent to our cold‑chain laboratory for high‑throughput sequencing. Results are interpreted by board‑certified molecular geneticists and returned within 3–4 weeks.
2. Can this test be done on newborns or during pregnancy?
Yes, the test can be performed on newborn blood spots or cord blood with appropriate consent. For prenatal diagnosis, amniocentesis‑derived DNA may be used; however, this requires a separate referral and genetic counselling. All pediatric testing must follow UAE personal data protection and medical liability regulations.
3. How should I prepare for the blood collection and what are the costs?
No fasting or special preparation is required; simply hydrate and continue prescribed medications. The fee is 2800 AED, inclusive of home collection, cold‑chain transport, sequencing, and a telephonic results discussion. We verify insurance eligibility via WhatsApp +971 54 548 8731 before the appointment.
UAE Regulatory & Data Privacy Adherence
This service operates under:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability
All genomic data is stored and processed within UAE‑approved secure infrastructure. DHA Facility License: 1143. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | WDR73 Gene Galloway-Mowat Syndrome Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole blood (peripheral), FTA card, or extracted genomic DNA |
| Methodology Used | Next Generation Sequencing (NGS) – Whole exome target enrichment |
| ICD-10-CM Code | Q87.8 (Galloway‑Mowat syndrome), Z13.71 (Encounter for screening for genetic anomalies), Z14.8 (Genetic carrier status) |
| LOINC Code | 101426‑0 — WDR73 gene variant analysis by NGS |
| DHA Facility License & Address | License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians